Clostridium novyi-NT in cancer therapy - Wikidata - wikimedia - TriplyDB

Clostridium novyi-NT in cancer therapy

Clostridium novyi-NT in cancer therapy

http://www.wikidata.org/entity/Q56566095

about

Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy.Branched Gold Nanoparticle Coating of Clostridium novyi-NT Spores for CT-Guided Intratumoral Injection.

P2860

Q47709474-E76BCEE4-DD07-4418-B8C8-FDE5405E1C83 Q50200275-2BF21C6C-A052-48E9-9F04-F5B11AEEA65D

P2860

Clostridium novyi-NT in cancer therapy

http://www.wikidata.org/entity/Q56566095

description

scientific article published on 06 February 2016

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2016

@uk

name

Clostridium novyi-NT in cancer therapy

@en

Clostridium novyi-NT in cancer therapy

@nl

type

label

Clostridium novyi-NT in cancer therapy

@en

Clostridium novyi-NT in cancer therapy

@nl

prefLabel

Clostridium novyi-NT in cancer therapy

@en

Clostridium novyi-NT in cancer therapy

@nl

P1433

Q56566095-19EAFEA6-D71A-472B-925A-2C75CBB0C28C

P1476

Q56566095-48C16134-D3D5-421C-B58A-A72FD0B2FD0D

P2093

Q56566095-050F1BCD-6CA1-4908-B7CF-1304AE6E3542

Q56566095-BE0DCC11-0D4B-4039-BED3-4F9250F69F7A

Q56566095-D1E53764-CB02-4FCA-8477-8475366C5475

P2860

Q56566095-02C7E4BD-7518-4A64-AD2A-642B128B5AA2

Q56566095-02D4EB7C-9866-4880-9880-3DCAE29C7F63

Q56566095-02DCBF90-635D-4E9C-998E-B05FAD114C94

Q56566095-0523F431-0A51-439D-894C-622F22D45A8F

Q56566095-07B51C43-9B2B-412E-A7D7-EF1E4EEB45F2

Q56566095-09A7CA13-1681-42D3-AB64-773AC8911D24

Q56566095-0BBCA18C-F748-4998-B011-C01DD58571DB

Q56566095-104B6B01-D8DF-4FCC-A7DB-6511E9BDA4ED

Q56566095-13A5A467-7235-4B81-AE21-7CA4B8B985EE

Q56566095-1B8CD76D-802F-4CB1-992C-8A8BF4D793DD

P304

Q56566095-9565AB5D-E94F-47DA-9DC0-795CA6A47105

P31

Q56566095-DA0A4072-09BA-432E-B0E9-7BE40AEEC1F7

P356

Q56566095-F7FC7DE1-1EFB-49AE-B2C0-CB960118A610

P433

Q56566095-09277255-5B09-4218-84D5-2D280C894ECC

P478

Q56566095-C2717829-2D25-4383-86FC-797763E7B34A

P50

Q56566095-AA35C47C-B281-4869-81D7-734E572C02B5

P577

Q56566095-473FD158-9EEE-4D85-969F-95A10C6E262C

P5875

Q56566095-EDFAE816-CB96-4CDA-8218-F5C2C35CFF8A

P698

Q56566095-D922E97E-9C41-41AC-B043-E30F179020BD

P932

Q56566095-86349E64-AD43-49ED-B8E2-BEBA912D0284

P356

J.GENDIS.2016.01.003

P1433

Genes & diseases

P1476

Clostridium novyi-NT in cancer therapy

@en

P2093

Ren-Yuan Bai

http://www.w3.org/2001/XMLSchema#string

Shibin Zhou

http://www.w3.org/2001/XMLSchema#string

Verena Staedtke

http://www.w3.org/2001/XMLSchema#string

P2860

Evolutionary dynamics of cancer in response to targeted combination therapy

Cancer genome landscapes

Hallmarks of Cancer: The Next Generation

Combination bacteriolytic therapy for the treatment of experimental tumors

Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Molecular mechanisms of T cell co-stimulation and co-inhibition

Reciprocal relationship between myeloid-derived suppressor cells and T cells

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

The blockade of immune checkpoints in cancer immunotherapy

P304

144-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.GENDIS.2016.01.003

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas J Roberts

P577

2016-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293329395

http://www.w3.org/2001/XMLSchema#string

P698

30258882

http://www.w3.org/2001/XMLSchema#string

P932

6150096

http://www.w3.org/2001/XMLSchema#string